MetaCap

Bio-Techne Stock Forecast

NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

72.67-0.03 (-0.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TECH analyst consensus

Consensus (13 analysts)

hold

Avg. price target

$70.50-2.99%

  • Strong buy 0
  • Buy 0
  • Hold 12
  • Sell 1
  • Strong sell 0

Target range

Low $50.00High $73.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

What analysts say

According to 13 Wall Street analysts covering Bio-Techne (2026-11-18), 0 rate the stock a buy or strong buy, 12 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $70.50, with a high estimate of $73.00 and a low estimate of $50.00. The average target implies downside of 3.0% from the current price of $72.67.

The spread between the highest and lowest targets is 46.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for TECH.

Summary generated from market data by MetaCap's automated system. Methodology

Rating distribution

Bio-Techne analyst rating distribution
RatingAnalystsShare
Strong buy00%
Buy00%
Hold1292%
Sell18%
Strong sell00%

Ratings as of 2026-11-18.

Price target scenarios

Price targets versus the current price
TargetPricevs. current
Low target$50.00-31.20%
Average target$70.50-2.99%
High target$73.00+0.45%

How analysts view Bio-Techne's peers

Peer analyst targets
CompanyConsensusPriceAvg. targetImplied move
RGENbuy163.81$203.21+24.05%
HALObuy91.35$120.11+31.48%
QGENhold49.30$49.77+0.95%
KYMRstrong_buy115.31$145.22+25.94%
KRYSstrong_buy308.89$388.22+25.68%
PCVXnone55.39$116.40+110.15%

Related